Search results
PROMOTED
How do worsening heart events dictate the long-term outcomes of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and can earlier intervention influence the disease trajectory in ATTR-CM? In this new sub-analysis from ATTRibute-CM, recorded onsite at ESC Heart Failure Congress (HFA) 2026, Prof Marianna Fontana (University College London, London, UK) sheds further light onto these…
View more
HFA 2026: Updates on ATTR-CM
Added:
2 days ago
Video Series
Cardio-oncology Practice in an Eastern European Country
Added:
2 weeks ago
Expert Opinion
Added:
1 year ago
ESC Congress — Ms Carys Barton (Imperial College Healthcare NHS Trust, London, UK) joins us on-site to talk about the implementation of heart failure guidelines.Interview Questions:1. What are the biggest challenges in implementing heart failure guidelines?2. How do nurses help implement guidelines, and what strategies do they use?3. What training can help with guideline implementation?4. How can…
View more
Added:
1 year ago
Host, Dr Dipti Itchhaporia (Hoag Heart and Vascular Institute, Newport Beach, CA, US) is joined by PI, Dr Derek Chew (Monash Heart and Victorian Heart Institute, AU) to discuss the findings from the RAPIDxAI trial, which aims to improve the assessment of suspected cardiac chest pain in emergency departments (ED) using a machine-learning algorithm that will interpret high-sensitivity troponin test…
View more
Added:
2 months ago
Prof Dominik Linz (Maastricht University Medical Centre, Maastricht, NL) moderates a discussion with Dr Emma Sandgren (Karolinska Institutet Danderyd Hospital, Stockholm, SE) and Dr Martin Manninger-Wünscher (Medical University of Graz, Graz, AU) on the clinical implementation and future potential of photoplethysmography (PPG) in atrial fibrillation management.The panel explores PPG's role as a…
View more
Added:
1 month ago
ACC.26 - In this expert interview filmed at ACC.26 in New Orleans, Prof. Felipe Martínez discusses how late-breaking heart failure data are reshaping contemporary pharmacological management. The conversation focuses on new spironolactone results, advanced hemodynamic strategies in HFpEF, and the expanding role of cardiometabolic therapies, including GLP‑1 receptor agonists, in optimising outcomes…
View more
Added:
1 month ago
ACC 2026 — Dr Deepak Bhatt (Mount Sinai Fuster Heart Hospital, US) delivers his expert verdict on three late-breaking clinical trials from ACC 2026 that are poised to influence cardiovascular care and future clinical guidelines.Dr Bhatt highlights data updates from the SURPASS-CVOT trial, exploring expanded cardiometabolic findings with tirzepatide versus dulaglutide, discusses the HI-PEITHO…
View more
Added:
3 months ago
Dr Tom De Potter (Cardiovascular Center, OLV Hospital, Aalst, BE) joins us to share his expert perspective on the five key developments poised to transform atrial fibrillation and electrophysiology practice in 2026.This forward-looking discussion examines emerging technologies, evolving clinical evidence, and shifting treatment paradigms that will influence day-to-day decision-making in…
View more
Added:
3 months ago
Arrhythmia Academy Editor-in-Chief Dr Luigi Di Biase shares his expert perspective on the most practice-changing clinical trials emerging from the latest advances in atrial fibrillation management.In this highlights discussion, Dr Di Biase distills the key evidence that is reshaping clinical decision-making in AF ablation, anticoagulation strategies, and rhythm control approaches. Drawing from…
View more
Added:
1 year ago
ECO 2024 — Prof Sven Francque (University of Antwerp, BE) joins us to talk about the new EASL-EASD-EASO Practice Guidelines for MAFLD.In this interview, Prof Francque highlights some of the unmet needs in people with MAFLD (formerly known as NAFLD). He then summarises the key highlights of the latest guidelines, including guidance on treatment options. He also discusses some of the challenges…
View more